ILC3s are gut-resident lymphocytes that have been indicated to play important roles in intestinal infection, autoimmunity, and tumors.4 Importantly, intestinal immunity has been associated with systemic diseases through neuronal and metabolic mechanisms.66,67 Our work is valuable for understanding the potential risks for therapies targeting Brg1. The gene discussed is SMARCA4; the disease is Autoimmunity.